Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection.

Patient preferences are mainly driven by dosing flexibility and simplicity, including freedom to take the medication with/without food. The role of PC in the diagnosis should be taken into account. There are still patients who are untreated after diagnosis.